SCHEMBL6274248

SCHEMBL6274248

CCCCOc1c(O)c2c(OCCCC(=O)O)cccc2oc1=O

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NQO1 P15559 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ CYSLTR2 Q9NS75 4/20 0.42
▸ CYSLTR1 Q9Y271 4/20 0.42
▸ CNR2 P34972 2/20 0.41
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NR1H4 Q96RI1 1/20 0.39
▸ CDC25A P30304 1/20 0.39
▸ CDC25B P30305 1/20 0.39
▸ CDC25C P30307 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6275908 0.97 ALDH1A1 (0.44) NQO1ALDH1A1CYSLTR2CYSLTR1CNR2
SCHEMBL6276104 0.96 CYSLTR2 (0.44) NQO1ALDH1A1CYSLTR2CYSLTR1NPSR1
SCHEMBL6274120 0.96 CYSLTR2 (0.44) NQO1ALDH1A1CYSLTR2CYSLTR1NPSR1
SCHEMBL6276022 0.95 NQO1 (0.43) NQO1ALDH1A1CYSLTR2CYSLTR1CNR2
SCHEMBL6276755 0.93 LTB4R (0.44) NQO1ALDH1A1CYSLTR2CYSLTR1CNR2
SCHEMBL6274289 0.93 LTB4R (0.44) NQO1ALDH1A1CYSLTR2CYSLTR1CNR2
SCHEMBL6275174 0.92 NQO1 (0.43) NQO1ALDH1A1CYSLTR2CYSLTR1NR1H4
SCHEMBL6272953 0.91 CYSLTR2 (0.43) NQO1CYSLTR2CYSLTR1NPSR1
SCHEMBL6272875 0.91 CYSLTR2 (0.43) NQO1CYSLTR2CYSLTR1NPSR1
SCHEMBL6272708 0.90 NQO1 (0.43) NQO1ALDH1A1CYSLTR2CYSLTR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
CN-1473565-A Benzopyrany/derivatives and antiallergic agent ���ձ���ī��ѧ��ʽ���� 2004-02-11 — — CN disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 NQO1 1320/4885ALDH1A1 105/4885CYSLTR2 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback